Cargando…
Evolution of multiple cell clones over a 29-year period of a CLL patient
Chronic lymphocytic leukaemia (CLL) is a frequent B-cell malignancy, characterized by recurrent somatic chromosome alterations and a low level of point mutations. Here we present single-nucleotide polymorphism microarray analyses of a single CLL patient over 29 years of observation and treatment, an...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171825/ https://www.ncbi.nlm.nih.gov/pubmed/27982015 http://dx.doi.org/10.1038/ncomms13765 |
_version_ | 1782484019597803520 |
---|---|
author | Zhao, Zhikun Goldin, Lynn Liu, Shiping Wu, Liang Zhou, Weiyin Lou, Hong Yu, Qichao Tsang, Shirley X. Jiang, Miaomiao Li, Fuqiang McMaster, MaryLou Li, Yang Lin, Xinxin Wang, Zhifeng Xu, Liqin Marti, Gerald Li, Guibo Wu, Kui Yeager, Meredith Yang, Huanming Xu, Xun Chanock, Stephen J. Li, Bo Hou, Yong Caporaso, Neil Dean, Michael |
author_facet | Zhao, Zhikun Goldin, Lynn Liu, Shiping Wu, Liang Zhou, Weiyin Lou, Hong Yu, Qichao Tsang, Shirley X. Jiang, Miaomiao Li, Fuqiang McMaster, MaryLou Li, Yang Lin, Xinxin Wang, Zhifeng Xu, Liqin Marti, Gerald Li, Guibo Wu, Kui Yeager, Meredith Yang, Huanming Xu, Xun Chanock, Stephen J. Li, Bo Hou, Yong Caporaso, Neil Dean, Michael |
author_sort | Zhao, Zhikun |
collection | PubMed |
description | Chronic lymphocytic leukaemia (CLL) is a frequent B-cell malignancy, characterized by recurrent somatic chromosome alterations and a low level of point mutations. Here we present single-nucleotide polymorphism microarray analyses of a single CLL patient over 29 years of observation and treatment, and transcriptome and whole-genome sequencing at selected time points. We identify chromosome alterations 13q14−, 6q− and 12q+ in early cell clones, elimination of clonal populations following therapy, and subsequent appearance of a clone containing trisomy 12 and chromosome 10 copy-neutral loss of heterogeneity that marks a major population dominant at death. Serial single-cell RNA sequencing reveals an expression pattern with high FOS, JUN and KLF4 at disease acceleration, which resolves following therapy, but reoccurs following relapse and death. Transcriptome evolution indicates complex changes in expression occur over time. In conclusion, CLL can evolve gradually during indolent phases, and undergo rapid changes following therapy. |
format | Online Article Text |
id | pubmed-5171825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51718252016-12-23 Evolution of multiple cell clones over a 29-year period of a CLL patient Zhao, Zhikun Goldin, Lynn Liu, Shiping Wu, Liang Zhou, Weiyin Lou, Hong Yu, Qichao Tsang, Shirley X. Jiang, Miaomiao Li, Fuqiang McMaster, MaryLou Li, Yang Lin, Xinxin Wang, Zhifeng Xu, Liqin Marti, Gerald Li, Guibo Wu, Kui Yeager, Meredith Yang, Huanming Xu, Xun Chanock, Stephen J. Li, Bo Hou, Yong Caporaso, Neil Dean, Michael Nat Commun Article Chronic lymphocytic leukaemia (CLL) is a frequent B-cell malignancy, characterized by recurrent somatic chromosome alterations and a low level of point mutations. Here we present single-nucleotide polymorphism microarray analyses of a single CLL patient over 29 years of observation and treatment, and transcriptome and whole-genome sequencing at selected time points. We identify chromosome alterations 13q14−, 6q− and 12q+ in early cell clones, elimination of clonal populations following therapy, and subsequent appearance of a clone containing trisomy 12 and chromosome 10 copy-neutral loss of heterogeneity that marks a major population dominant at death. Serial single-cell RNA sequencing reveals an expression pattern with high FOS, JUN and KLF4 at disease acceleration, which resolves following therapy, but reoccurs following relapse and death. Transcriptome evolution indicates complex changes in expression occur over time. In conclusion, CLL can evolve gradually during indolent phases, and undergo rapid changes following therapy. Nature Publishing Group 2016-12-16 /pmc/articles/PMC5171825/ /pubmed/27982015 http://dx.doi.org/10.1038/ncomms13765 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Zhao, Zhikun Goldin, Lynn Liu, Shiping Wu, Liang Zhou, Weiyin Lou, Hong Yu, Qichao Tsang, Shirley X. Jiang, Miaomiao Li, Fuqiang McMaster, MaryLou Li, Yang Lin, Xinxin Wang, Zhifeng Xu, Liqin Marti, Gerald Li, Guibo Wu, Kui Yeager, Meredith Yang, Huanming Xu, Xun Chanock, Stephen J. Li, Bo Hou, Yong Caporaso, Neil Dean, Michael Evolution of multiple cell clones over a 29-year period of a CLL patient |
title | Evolution of multiple cell clones over a 29-year period of a CLL patient |
title_full | Evolution of multiple cell clones over a 29-year period of a CLL patient |
title_fullStr | Evolution of multiple cell clones over a 29-year period of a CLL patient |
title_full_unstemmed | Evolution of multiple cell clones over a 29-year period of a CLL patient |
title_short | Evolution of multiple cell clones over a 29-year period of a CLL patient |
title_sort | evolution of multiple cell clones over a 29-year period of a cll patient |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171825/ https://www.ncbi.nlm.nih.gov/pubmed/27982015 http://dx.doi.org/10.1038/ncomms13765 |
work_keys_str_mv | AT zhaozhikun evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT goldinlynn evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT liushiping evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT wuliang evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT zhouweiyin evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT louhong evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT yuqichao evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT tsangshirleyx evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT jiangmiaomiao evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT lifuqiang evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT mcmastermarylou evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT liyang evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT linxinxin evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT wangzhifeng evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT xuliqin evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT martigerald evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT liguibo evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT wukui evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT yeagermeredith evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT yanghuanming evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT xuxun evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT chanockstephenj evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT libo evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT houyong evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT caporasoneil evolutionofmultiplecellclonesovera29yearperiodofacllpatient AT deanmichael evolutionofmultiplecellclonesovera29yearperiodofacllpatient |